We analysed the regulation of G1-phase progression in relation to cytokine receptor signalling in HepG2 hepatoma cells, stably transduced with the IL-10 receptor after stimulation with Oncostatin M (OSM), IL-6, Leukaemia Inhibitory Factor (LIF) and IL-10. All cytokines induced STAT3 phosphorylation to approximately the same level, but only OSM, and to a lesser extent IL-6, induced STAT5 phosphorylation. The cytokines also stimulated phosphorylation of ERK in the order of decreasing eectiveness: OSM4IL-64LI-F4IL-10. The same order of activity of the cytokines was observed on inhibition of DNA synthesis and accumulation of cells in the G1-phase of the cell cycle. These processes were accompanied by a decrease in cyclin A expression and CDK2 activity, and enhanced accumulation of p27kip1. The level of p27kip1 mRNA expression was unaected by the cytokines, and maintenance of the elevated level of p27kip1 occurred independently of de novo protein synthesis. Furthermore, inhibition of proteasomal activity increased the level of p27kip1 in the unstimulated cells to the same level as in OSM-treated cells. Inhibition of MEK activation completely abrogated OSM and IL-6 induced p27kip1 accumulation, while expression of dominant negative STAT5 decreased the OSM and IL-6 mediated inhibition of DNA-synthesis and partially inhibited p27kip1 accumulation. Oncogene (2000) 19, 3675 ± 3683.
Introduction
The family of Interleukin (IL) 6 cytokine receptors structurally belongs to the class I cytokine receptors and is de®ned by the shared usage of gp130 to transduce the receptor signals (Bazan, 1990) . This family includes the receptors for IL-6, Oncostatin M (OSM) and Leukaemia Inhibitory Factor (LIF). Treatment of hepatocytes with these cytokines induces production of acute phase proteins in part through activation of the signal transducers and activators of transcription (STAT) 3 pathway (Lai et al., 1996) . We and others have also shown that the class II cytokine receptor IL-10 receptor (IL-10R) is eective in engaging STAT3 and this receptor, when expressed in HepG2 cells, functions similar to the endogenous IL-6R, resulting in the induction of acute phase protein gene transcription through IL-6 response elements (Lai et al., 1996) .
Diverse roles of the IL-6-type cytokines in controlling cell growth have been described: On one side IL-6 is an important growth factor for lymphocytes and myeloma cells (Kawano et al., 1988) , on the other side OSM, IL-6 and LIF inhibit growth of breast cancer cells (Douglas et al., 1997) and OSM and IL-6 inhibit growth of melanoma and lung cancer cells (Lu et al., 1992; Takizawa et al., 1993 , Horn et al., 1990 . The eects of gp130 on cell proliferation invariably involve altered activity of cell cycle regulatory proteins. Recently, it has been shown that OSM and IL-6 induce upregulation of the cyclin-dependent kinase inhibitor (CDKI) p27kip1 mRNA and protein in melanoma cells (Kortylewski et al., 1999) . This suggests that growth inhibition in these cells by the cytokines may be caused by inhibition of cyclindependent kinase (CDK) activity by p27kip1.
We have previously observed an inverse relationship of proliferation and regulation of acute phase protein gene expression in hepatic cells Wang et al., 1999) . In this study we determine to what extent IL-6 cytokines and IL-10 aect G1-phase progression in HepG2 cells, which respond to these cytokines by induction of type 2 acute phase proteins. We show that signalling through the OSMR and IL-6R, but not through LIFR or IL-10R, results in p27kip1 accumulation and G1-arrest. This process appears to be correlated with suppressed p27kip1 degradation by the proteasome pathway and sensitive to the cytokine activated extracellular signal regulated kinase (ERK) and STAT5 pathways.
Results

Activation of STAT3, STAT5 and ERK defines different relative activities for OSM, IL-6, LIF and IL-10
We compared the ability of OSM, IL-6, LIF and IL-10 to activate the janus kinase (JAK)/STAT pathway and ERK pathway in HepG2 cells stably transduced with the IL-10 receptor (HepG2-IL-10R). We found that all four cytokines induced comparable tyrosine phosphorylation of STAT3 (Figure 1a,c) . Phospho-STAT3 was readily detectable within 5 min of stimulation, and phosphorylation above basal level was noted for up to 48 h. As previously reported, OSM, and to a far lesser extent IL-6, also induce tyrosine phosphorylation of STAT5 (Auguste et al., 1997; Lai et al., 1996) , but we were unable to detect STAT5 phosphorylation by IL-10 and LIF ( Figure  1c ). Although the latter cytokines stimulated phos-phorylation of ERK, the relative activity identi®ed after 15 min treatment followed the order: OSM4IL-64LIF4IL-10 (Figure 1b,c) . The kinetics of ERK phosphorylation also varied among the cytokines. The OSM induced ERK phosphorylation peaked after 15 ± 30 min of incubation, declined after 2 h of incubation, but was still detectable after 48 h of incubation. The IL-6 induced ERK phosphorylation peaked after 15 min and was only slightly reduced during the ®rst 24 h of incubation. LIF induced ERK phosphorylation less eectively and with delayed kinetics compared to OSM and IL-6, whereas we only could detect very weak ERK phosphorylation following IL-10 stimulation. Furthermore, OSM was able to induce maximal Figure 1 Kinetics and dose-response pro®les for STAT3 and ERK phosphorylation in HepG2-IL-10R cells. (a) P-STAT3 and (b) P-ERK Western blots. Cells were treated with 100 ng/ml of the cytokines at the indicated time points and lysed as described in Materials and methods. For the dose-response experiments, cells were stimulated for 15 min. (c) Comparison of the cytokines ability to activate STAT3, ERK and STAT5. Cells were treated for 15 min with 100 ng/ml of the cytokines and lysates analysed as above p27kip1 regulation by IL-6 type cytokines and IL-10 P Klausen et al ERK phosphorylation at a 10-fold lower dose than the other cytokines investigated (Figure 1b) . Thus, while these cytokines are equipotent in induction of STAT3 phosphorylation, they dier in their ability to induce STAT5 and ERK activation. OSM elicits the strongest response followed by IL-6, LIF and IL-10, respectively.
OSM and IL-6, but not LIF and IL-10, inhibit DNA synthesis and arrest HepG2-IL-10R cells in the G1 phase of the cell cycle
We next determined the eect of these cytokines on S phase progression and DNA synthesis. IL-6 and OSM, but not IL-10 and LIF, increased the fraction of cells in the G1-phase after 24 h of culture, as assessed by propidium iodide staining of isolated nuclei and owcytometric analysis (Figure 2a) . The OSM and IL-6 induced G1-arrest was even more pronounced after 48 h of culture and was accompanied by a corresponding decrease in the fraction of cells in S/G2/ M phases. The reduction of cells in S phase was con®rmed by a proportional decrease of DNA synthesis after 24 h of cytokine treatment. Again, OSM proved to be more potent than IL-6, whereas LIF and IL-10 gave only a very modest inhibition of DNA synthesis (Figure 2b ).
OSM and IL-6, but not LIF and IL-10, upregulate p27kip1 protein expression and inhibit CDK2 activity
The data of Figure 2 suggested that the eects of OSM and IL-6 were likely activated through modulating the activity of the CDKs controlling G1/S transition. We therefore investigated the eect of the cytokines on expression of cyclin D1, cyclin E and cyclin A proteins. The levels of cyclin D1 and cyclin E did not change upon stimulation with any of the four cytokines, whereas the expression of cyclin A protein was signi®cantly decreased when the cells were cultured in the presence of OSM and IL-6, but not LIF and IL-10 ( Figure 3a ). This expression pattern con®rmed the OSM and IL-6 induced G1-arrest. The stable levels of cyclin E and cyclin D1 further suggested that the molecule(s) responsible for growth inhibition was likely to be a CIP/KIP family member of CDKIs, since the expression of cyclin E is dependent on CDK4/6 activity and the INK4 family of CDKIs speci®cally inhibit CDK4/6 (Bartek et al., 1997) . We next investigated the expression of the three CIP/KIP family of CDKIs: p27kip1, p21cip1 and p57kip2 and found that OSM and IL-6, but not IL-10 and LIF, signi®cantly upregulated the expression of p27kip1 protein after 24 and 48 h of incubation ( Figure 3a) . We also observed trace amounts of p21cip1 protein in the presence of OSM and IL-6, but since the basal level of p21cip1 was not detectable, a small increase of p21cip1 protein mediated by LIF and IL-10 could be below the level of detection. We did not see any change in the expression of p57kip2 protein, regardless of cytokine stimulation ( Figure 3a) .
In order to con®rm that OSM and IL-6 induced inhibition of cell growth was exerted in late G1, we performed an in vitro kinase assay on CDK2. Consistent with the analysis of the expression of cell cycle regulatory proteins, OSM and IL-6, but not LIF and IL-10, signi®cantly inhibited CDK2 activity, while none of the cytokines aected the level of CDK2 protein expression (Figure 3b ). Since CDK2 is Figure 3 Altered activity and expression of cell cycle proteins mediated by OSM and IL-6 in HepG2-IL-10R cells. (a) Western blots showing the levels of the CIP/KIP family of inhibitors: p27kip1, p21cip1 and p57kip2, and cyclin D1, cyclin E and cyclin A following 24 and 48 h of treatment with 100 ng/ml of the cytokines. As an internal loading control all blots were probed with antibodies recognizing STAT3 (data not shown). The shown experiments are representative for 3 ± 6 independent experiments. (b) Kinase activity (top) and protein level (bottom) of CDK2 after 24 h of treatment with 100 ng/ml of the cytokines. The shown kinase assay is representative for four independent experiments p27kip1 regulation by IL-6 type cytokines and IL-10 P Klausen et al inhibited by the CIP/KIP family of CDKI's exclusively (Sherr, 1996) , these data indicate that the accumulation of p27kip1 protein in the presence of these cytokines leads to decreased CDK2 activity. Moreover, the ability to do so, follows the same order of responsiveness as we observed for induction of STAT5 and ERK phosphorylation, and growth inhibition (Figures 1 ± 3 ).
p27kip1 accumulation is caused by inhibition of p27kip1 degradation
We next performed a semi-quantitative RT ± PCR assay in order to assess if the accumulation of p27kip1 protein mediated by OSM and IL-6 was due to activation of p27kip1-gene transcription. We cultured HepG2-IL-10R cells for 24 h in the presence or absence of the cytokines and isolated total cellular RNA. Using primers for haptoglobin (Hp), glyceraldehyde 3-phosphatase dehydrogenase (GAPDH) and p27kip1, we performed a series of parallel RT ± PCR ampli®cations, from which we withdrew samples after each cycle in the range between 18 and 30 cycles. This procedure allowed us to identify the cycle number in which the speci®c amplicon became visible on agarose gels. We found that the cycle number in which the GAPDH and p27kip1 amplicons became detectable was unaected by cytokine treatment, whereas the number of PCR-cycles needed to visualize the positive control haptoglobin amplicon decreased with stimulus ( Figure 4a ). These results indicate that the level of p27kip1 mRNA expression is independent of signalling through gp130 or the IL-10R in our system. Further experiments with the inhibitor of protein synthesis cycloheximide (CHX), supported this hypothesis. Pre-treatment of the cells with CHX for 30 min and subsequent stimulation with the cytokines for 15 h, did not aect OSM or IL-6 induced p27kip1 accumulation, whereas cyclin D1 expression, which served as a positive control for the eect of CHX, was signi®cantly downregulated in the presence of CHX (Figure 4b ). These data demonstrate that p27kip1 accumulation is independent of de novo protein synthesis, thus suggesting that the OSM and IL-6 induced upregulation of p27kip1 expression may be caused by inhibition of p27kip1 degradation.
It has previously been reported that p27kip1 protein degradation can be mediated by ubiquitination and proteasomal destruction (Pagano et al., 1995) . We therefore preincubated the cells for 30 min with the inhibitor of proteasomal activity MG132 and subsequently stimulated with the cytokines for 24 h. The inhibition of proteasomal activity increased the level of p27kip1 protein in the untreated cells to the level achieved in OSM treated cells ( Figure 5 ). These data indicate that OSM, and to a lesser extent IL-6, increase the protein level of p27kip1 by preventing its degradation by the proteasome. Moreover, the level of p21cip1, which was only slightly altered by treatment with OSM and IL-6, increased when the cells were preincubated with MG132 ( Figure 5 ), consistent with the reported regulation of p21cip1 expression through proteasomal activity (Blagosklonny et al., 1996) .
Accumulation of p27kip1 and inhibition of DNA synthesis are dependent on ERK and STAT5 activity
We next assessed the dependence of p27kip1 upregulation on ERK and STAT5 activation by the cytokines. Pre-treatment of HepG2-IL-10R cells for 30 min with the MEK inhibitor UO126 and subsequent stimulation with the cytokines for 24 h decreased the basal [ 3 H]thymidine incorporation, and strongly but not completely blocked the response to OSM and IL-6 (Figure 6a ). Incubation with UO126 in the presence of the cytokines for 15 min completely inhibited ERK phosphorylation without aecting STAT3 phosphorylation (Figure 6b ). The ERK inhibitory eect of Figure 4 OSM and IL-6 increase p27kip1 protein in HepG2-IL-10R cells by a posttranslational mechanism. (a) Cells were stimulated with the cytokines for 24 h and RNA was prepared as described in Materials and methods. Series of parallel RT ± PCR ampli®cations, from which samples were withdrawn after each cycle in the range between 18 and 30 cycles were then performed for p27kip1, Haptoglobin (Hp) and GAPDH (internal control). The earliest cycle number where speci®c amplicons for p27kip1, Hp and GAPDH were visible on agarose gels is plotted on the graph. The shown experiment is representative for three independent experiments. (b) HepG2-IL-10R cells were pretreated for 30 min with PBS or 10 mg/ml cycloheximide (CHX) prior stimulation with the cytokines. The cells were lysed following 15 h of incubation, and subjected to Western blot. The level of cyclin D1 functioned as a positive control for the eect of CHX. STAT3 expression was used as a loading control Figure 5 OSM and IL-6 regulate p27kip1 in HepG2-IL-10R cells by inhibiting proteasomal activity. Cells were preincubated for 30 min with dimethyl sulfoxide (DMSO) or 1 mg/ml MG132 prior stimulation with the cytokines for 24 h, lysed and subjected to Western blot. The increase in the level of p21cip1 protein was used as a positive control for the eect of MG132. STAT3 expression was used as a loading control Oncogene p27kip1 regulation by IL-6 type cytokines and IL-10 P Klausen et al UO126 was sustained up to 24 h of incubation (data not shown). Pre-treatment of HepG2-IL-10R cells with UO126 and subsequent stimulation with the cytokines for 24 h strongly inhibited OSM and IL-6 induced p27kip1 protein accumulation (Figure 6c ). Identical results were obtained with another MEK inhibitor PD98059 (data not shown). We observed a signi®cant upregulation of p21cip1 protein, when the cells were cultured in the presence of UO126 (Figure 6c ). This may explain the decrease in [ 3 H]thymidine incorporation. The upregulation of p21cip1 expression in the absence of ERK activity was not due to induction of p53 protein, as the level of p53 was unaected by incubation with UO126 (data not shown).
We ®nally used HepG2 cells, stably transfected with a dominant negative STAT5 mutant (STAT5D40C), to investigate the role of STAT5 in the OSM and IL-6 induced growth inhibition. The expression of STAT5D40C was detectable by Western blotting (Figure 6e, right panel) . STAT5 is a speci®c mediator of IL-3R signals (Chin et al., 1996) , thus the eectiveness of STAT5D40C to inhibit transcriptional function of STAT5 was identi®ed by its activity to abolish activity of transiently introduced IL-3R expression (Figure 6d ). The inhibitory eects of cytokines on DNA-synthesis in the presence of STAT5D40C were decreased 20% compared to parental HepG2 and the inhibited suppression appears to be correlated with the relative level of STAT5D40C proteins (Figure 6e ). OSM and IL-6 stimulation of p27kip1 accumulation was concordantly decreased in HepG2-STAT5D40C cells (Figure 6f compared to Figures 3a and 4b) .
Discussion
In this study we demonstrate that cell cycle arrest caused by OSM and IL-6 in hepatoma cells is correlated with inhibited degradation of the CDKI p27kip1. This is based on three observations: (1) p27kip1 accumulation in the presence of OSM and IL-6 occurs without concomitant increase in the expression level of p27kip1 mRNA; (2) In OSM and IL-6 treated cells, the level of p27kip1 protein is maintained high independently of new protein synthesis; and (3) The ability of OSM and IL-6 to enhance p27kip1 is abrogated in the presence of an inhibitor of proteasomal activity.
These data are in agreement with reports from several laboratories showing that p27kip1 is regulated translationally and post-translationally, rather than at the level of transcription (Hengst and Reed, 1996; Agrawal et al., 1996; Pagano et al., 1995) . In contrast, Kortylewski et al. (1999) have recently reported that OSM and IL-6 induce p27kip1 mRNA and protein in melanoma cells. We have tested the eects of mouse OSM, IL-6 and LIF on p27kip1 protein in rat H-35 hepatoma cells stably transduced with mouse OSMR and in mouse NIH3T3 ®broblasts, and found that OSM and IL-6 only caused a weak increase of p27kip1 protein in the H-35 cells, whereas we did not observe any appreciable change in the ®broblasts (data not shown). Thus the mechanisms by which OSM and IL-6 regulate p27kip1 expression are likely to depend on the cell type. We have previously demonstrated that induction of gene transcription mediated through gp130 is in part dependent on STAT3 activity Baumann, 1997, 1999; Kim et al., 1998; Lai et al., 1995 Lai et al., , 1996 Lai et al., , 1999 . We have also demonstrated that the receptor activity and the STAT3 signal can be moderated by recruitment of protein tyrosine phosphatase 2 (SHP-2) to tyrosine 759 in the cytoplasmatic domain of gp130 (Kim et al., 1998; Kim and Baumann, 1999) . The recruitment of SHP-2 to the receptor has two consequences: (1) down-regulation of JAK activity; and (2) activation of the MAP-kinases ERK-1 and ERK-2 . We now show that while cytokines signalling through gp130 and IL-10R are equally eective in induction of STAT3 activity and in transcription of acute phase protein genes (Lai et al., 1996) , they dier signi®cantly in their ability to activate ERK and STAT5. The dierence among the IL-6 cytokines we attribute to the signalling reactions executed by the LIFRa and OSMRb subunits that interact with gp130 to form the signal-transducing complex. We also assume that receptor speci®c downstream eects are likely causal to the regulation of proliferation. Only OSM and IL-6, and not LIF and IL-10, were able to promote substantial G1-arrest, inhibition of CDK2 activity and DNA synthesis, and accumulation of p27kip1 protein. Importantly, the accumulation of p27kip1 protein did not appear to be mediated at the level of gene transcription, but by an ERK and STAT5 dependent signal that interferes with p27kip1 degradation.
Degradation of p27kip1 can be achieved by ubiquitination followed by proteasome mediated degradation (Pagano et al., 1995) . It has previously been reported that CDK2 mediated phosphorylation of p27kip1 on threonine residue 187, is a prerequisite for proteasomal degradation of p27kip1 (Vlach et al., 1997; Shea et al., 1997; Montagnoli et al., 1999; Morisaki et al., 1997) . Following phosphorylation by CDK2, p27kip1 appears to be transported by a carrier protein (Jab1) from the nucleus to the cytoplasm, where it is ubiquitinated and degraded by proteasomes (Tomoda et al., 1999) . Thus, the stability of p27kip1 protein is dependent on CDK2 activity and the mediated activation of STAT3 activity is not in¯uenced by incubation with UO126. (c) Western blot showing the eect of UO126 on the level of p21cip1 and p27kip1 expression. STAT3 functions as an internal loading control. (d) Parental HepG2 cells (Control) and HepG2 cells stably expressing STAT5B with C-terminal truncation (STAT5D40C) were transiently transfected with pHRRE-CAT (15 mg/ml) and expression vector for IL-3Ralpha, IL-3Rbeta, and IL-10R (1 mg/ml each). Subcultures were treated for 24 h with the cytokines indicated at the bottom and the CAT activity determined (lower panel). The CAT activity in serially diluted cell extract was calculated relative to the untreated control in each series and is expressed in fold stimulation (upper panel) . (e) Cells were treated for 24 h in the presence of the cytokines and [ Oncogene p27kip1 regulation by IL-6 type cytokines and IL-10 P Klausen et al intracellular localization of p27kip1. We found that inhibition of the proteasome results in accumulation not only of p27kip1, but also of another CDKI, p21cip1. By contrast, inhibition of MEK and thus ERK activity, abrogates accumulation of p27kip1 but not of p21cip1. These results suggest that the mechanism by which OSM and IL-6 prevent p27kip1 degradation is dependent on MEK and/or ERK activity, and may not involve a general inhibition of proteasomal activity. Furthermore, the speci®city of cytokine action is underscored by the fact that we do not observe any signi®cant alterations in the expression of the third CIP/KIP family CDKI, p57kip2, or the expression level of cyclin D1 and cyclin E. The expression of cyclin E is dependent on CDK4 activity, which in turn is dependent on the expression level of cyclin D and level of inhibition by INK4 CDKIs (Sherr, 1996; Bartek et al., 1997) . Therefore, the unaltered expression of cyclin D and E in the presence of OSM and IL-6, suggest that these cytokines do not increase INK4 CDKI levels, since this should result in downregulation of cyclin E expression.
In a number of cancers the expression of p27kip1 is related to prognosis (Tsihlias et al., 1999; Cariou et al., 1998) . The ability of OSM and IL-6 to induce growth arrest in in vitro models of these tumours are very consistent with the results we report here. In line with our data, it has recently been shown that mantle cell lymphomas downregulate p27kip1 protein by increased activity of the proteasomal pathway (Chiarle et al., 2000) Thus, the signalling pathways involved in the regulation of p27kip1 degradation may oer novel therapeutic targets in cancer.
Materials and methods
Cells, cytokines and inhibitors
HepG2 cells stably expressing the a-chain of the human IL-10R have been described (Lai et al., 1996) . HepG2 cells stably expressing STAT5B with C-terminal truncation, STAT5BD40C , were similarly generated by transducing the double-copy, bicistronic retroviral vector (Wiznerowicz et al., 1998) containing the cDNA for rat STAT5BD40C. From the original transduced cell population, 24 separate clonal lines were generated and these were analysed for the relative expression of STAT5BD40C (Figure 6e ) and responsiveness to cytokine treatment. Most experiments presented in this study were carried out with a clonal line termed`HepG2-STAT5D40C'. To demonstrate the in¯uence of STAT5BD40C on proliferation control, clonal lines with dierent levels of STAT5BD40C expression were used. The cells were cultured in Dulbecco's modi®ed Eagle's medium (Life Tech) with 10% foetal calf serum (Gibco). Depending upon the experimental settings, the cells were treated for various length of time with 100 ng/ml (unless otherwise indicated) of recombinant human (rhu) IL-10 (Schering-Plough Research Institute), rhuIL-6 (Sandoz), rhuOSM (Immunex Corporation) and rhuLIF (Genetics Institute). For inhibition studies, cells were preincubated for 30 min with either 10 mg/ml cycloheximide (Sigma), 10 mM MG132 (Calbiochem) or 25 mM UO126 (Calbiochem), and subsequently treated with the cytokines.
Cell cycle analysis and DNA-synthesis
For cell cycle analysis cells were harvested, washed and lysed in ice-cold modi®ed Vindelov buer (0.1% sodium citrate pH 7.4, 0.02 mg/ml RNAse A, 0.37% NP-40, 0.5 mg/ml propidium iodide (PI) in the dark. The intensity of PIlabelling in the isolated nuclei was then measured on a FACScan¯ow cytometer (Becton Dickinson 
Western blotting
Cells were washed twice in ice-cold PBS and lysed in ice-cold RIPA buer (50 mM Tris pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM Na 3 VO 4 , 1 mM NaF, 10% glycerol, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin). Forty micrograms total cell lysate was applied on 10 ± 12% SDS gels, and transferred proteins reacted with antibodies either recognizing PY-ERK, PY-STAT3, PY-STAT5 (New England Biolabs), ERK, STAT3, STAT5, cyclin D1, cyclin A, cyclin E, CDK2, p57kip2 (Santa Cruz Biotechnology Inc.) or p27kip1, p21cip1 (Transduction Laboratories). The immune complexes were visualized by the enhanced chemiluminiscence reaction (Amersham Pharmacia Biotech).
Immunoprecipitation and histone H1 kinase assay
Cells were lysed in ice-cold lysis buer (50 mM Tris-HCl pH 7.5, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 0.1 mM Na 3 VO 4 , 1 mM NaF, 10 mM sodium pyrophosphate, 10 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml pepstatin, 20 mg/ml aprotinin). Total cell lysate was incubated with antibodies recognizing C-terminal cyclin E (Santa Cruz Biotecnology Inc.) and precipitated onto protein A-sepharose beads (Amersham Pharmacia Biotech). The precipitate was washed twice in lysis buer, once in 50 mM Tris-HCl pH 7.5, 1% sodium deoxycholate, 1% Triton X-100 and once in kinase assay buer (40 mM Tris-HCl pH 7.5, 15 mM MgCl 2 ). The precipitate was incubated in 5 ml kinase assay buer including 10 mCi [g-32 P]ATP (Amersham Pharmacia Biotech) and 2 mg histone H1 (Boehringer Mannheim) for 30 min at 378C and applied onto 12% SDS gels. The gel was subsequently stained in coomassie brilliant blue, dried and subjected to autoradiography.
Semiquantitative RT ± PCR
Cells were stimulated for 24 h, lysed in Trizol (Gibco) and RNA puri®ed. The primers used were: Upstream: 5'-TGCAGAGACATGGAAGAGGC-3' and downstream: 5'-CGTTTGACGTCTTCTGAGGC-3' for p27kip1; Upstream: 5'-TCTAGACGGCAGGTCAGGTCCACC-3' and downstream: 5'-CCACCCATGGCAAATTCCATGGCA-3' for GAPDH; and Upstream: 5'-CACCCTAACTACTCCCAAG-TAG-3' and downstream: 5'-AGGAGGACACCTGG-TATGCGA-3' for Hp. One microgram (p27kip1) or 100 ng (GAPDH and Hp) of total RNA was placed in 20 ml of RTbuer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 5 mM MgCl 2 , 10 mM dithiothreitol) with 250 mM each of deoxyribonucleoside triphosphate (Promega), 2 mg Oligo(dT) 24 (Life Tech), 50 U rRNasin ribonuclease inhibitor (Promega), 25 U AMV reverse transcriptase (Promega). The reaction mixture was incubated at 258C for 10 min, at 428C for 1 h, at 958C for 5 min and diluted 10-fold in water. An aliquot (10 ml) of each was placed in 100 ml of 16PCR buer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 2.5 mM MgCl 2 ) with 200 mM each of deoxyribonucleoside triphosphate (Promega), 0.2 mM each of primers and 1.5 U recombinant Taq DNA polymerase (Promega). cDNA was denatured at 948C for 5 min. Eighteen to 30 cycles were performed at 948C for 30 s, at 608C for 30 s and at 728C for 60 s for each cycle in a DNA thermal cycler p27kip1 regulation by IL-6 type cytokines and IL-10 P Klausen et al (PE Biosystems) and placed on ice. Depending upon the experimental settings the cDNA was ampli®ed for 18 ± 30 cycles. The reaction products were examined on 3% agarose gels.
Chloramphenicol acetyl transferase (CAT) assay
Cells were transfected with pHRRE-CAT and expression vectors for IL-3Ra and IL-3Rb, and CAT assay was performed as described in Morella et al. (1995) .
